J&J | JNJ - Operating Expenses



J&J reported $16.8B in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
AbbVie USD 9.71B 96M Jun/2025
Abbott USD 9.07B 369M Jun/2025
Amgen USD 6.52B 337M Jun/2025
AstraZeneca USD 10.95B 1.04B Jun/2025
Baxter International USD 2.54B 29M Jun/2025
Bayer EUR 10.73B 688M Jun/2025
Becton, Dickinson and Co. USD 4.53B 196M Jun/2025
Biogen USD 1.79B 326.1M Jun/2025
Boston Scientific USD 4.12B 377M Jun/2025
Bristol-Myers Squibb USD 8.5B 265M Jun/2025
CONMED USD 304.18M 1.11M Jun/2025
Cooper Companies USD 884.6M 67.1M Jul/2025
Dexcom USD 944.5M 42.2M Jun/2025
Edwards Lifesciences USD 1.1B 83.4M Jun/2025
Eli Lilly USD 8.54B 1.22B Jun/2025
Gilead Sciences USD 4.35B 80M Jun/2025
GlaxoSmithKline GBP 5.96B 663M Jun/2025
Globus Medical USD 1.62B 1.12B Jun/2025
Hologic USD 762.9M 249.4M Jun/2025
Insulet USD 528M 8.3M Jun/2025
Integra LifeSciences USD 416.91M 18.3M Jun/2025
Intuitive Surgical USD 1.69B 17.8M Jun/2025
J&J USD 16.8B 8.54B Jun/2025
Medtronic USD 7.06B 430M Jul/2025
Merck USD 9.44B 217M Jun/2025
Merit Medical Systems USD 335.44M 21.12M Jun/2025
Novartis USD 9.97B 1.02B Jun/2025
Pfizer USD 11.62B 1.58B Jun/2025
Regeneron Pharmaceuticals USD 2.6B 159.1M Jun/2025
Roche Holding CHF 11.43B 1.48B Dec/2024
Sanofi EUR 9.02B 702M Jun/2025
Stryker USD 4.85B 175M Jun/2025
Tandem Diabetes Care USD 272.54M 82.76M Jun/2025
Teva Pharmaceutical Industries USD 3.28B 95M Jun/2025
Vertex Pharmaceuticals USD 1.81B 71.4M Jun/2025
Zimmer Biomet Holdings USD 1.68B 110.7M Jun/2025
Zoetis USD 1.44B 35M Jun/2025